How does a delay in initiating triple therapy affect patients with COPD with a history of several moderate COPD exacerbations during a 1-year period?

Should patients without cancer who have recovered from severe COVID-19 infection be referred to post-COVID clinics based on their risk for interstitial lung disease?

Researchers assessed the effect of COPD severity on mortality and other outcomes of coronary artery bypass grafting.

How does cannabis affect COPD? To determine this, researchers assessed the risk for acute exacerbations of COPD in those who used cannabis vs those who did not.

Can patients with allergic asthma benefit from omalizumab even if they fall outside the criteria put forth in the approved recommended dosing table?

Post hoc analysis of a real-world COPD trial assessed the effect of triple therapy in reducing exacerbations in patients with higher vs lower eosinophil levels.

How accurate is shape-sensing robotic-assisted bronchoscopy with cone-beam CT image-guided sampling, a novel approach to detecting lung cancer?

Researchers sought to analyze the relationship between patient comorbidities and poor outcomes following ECMO treatment.

A study was conducted to assess if statin use in patients with IPF can prevent development of lung cancer.

Researchers studied the changes of pulmonary artery systolic pressure among patients with interstitial lung disease associated with systemic sclerosis receiving rituximab therapy.

Can upfront empiric community-acquired pneumonia antimicrobial therapy reduce ventilator-associated pneumonia rates in patients with COVID-19 requiring MV?

Post hoc analysis of the VENTURE/TRAVERSE trials assessed dupilumab efficacy in patients with severe asthma requiring varying levels of oral corticosteroids at baseline.

What are the risk factors and optimal treatments for residual pulmonary radiological and functional abnormalities in patients who have had COVID-19-related ARDS?

The CLEAR study compared clinical outcomes and health resource usage in patients with severe asthma who continued, switched, or stopped their biologic treatment.

Is mortality worse among patients with sepsis who have a history of ulcerative colitis or Crohn’s disease — and what complications are more common in these patients?

Investigators explored the value of treating patients with bronchiolitis in primary Sjogren’s Syndrome using inhaled corticosteroids and long-acting beta agonists.

Investigators developed and validated a machine learning tool providing an early indication of disease progression in community-acquired pneumonia.

What is the incidence of probiotic-associated central line infections in the ICU — and do the risks posed by these infections outweigh the benefits of probiotics?

A post hoc analysis of the NAVIGATOR trial assessed the effectiveness of tezepelumab in patients with severe asthma who used additional controllers medications.

Study authors sought to assess how a history of liver cirrhosis affected patients undergoing IMV with respect to mortality, long-term ventilator dependence, and health care resources.

Is the use of proton pump inhibitors associated with empyema and lung abscess? Presenters at CHEST 2022 analyzed a large data base to address this question.

To better understand SABA usage and its implications, investigators examined prescription fulfillment patterns among patients with all levels of asthma severity.

Researchers sought to investigate characteristics of computed tomography findings for patients with COVID-19 1 year after recovery.

In patients with COPD and asthma who are hospitalized for COVID-19, how does pre-hospitalization ICS use affect the clinical course of COVID-19?